First NYSE-listed TCM Firm Faces Buyout
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Tongjitang Chinese Medicine Company has received a proposal letter for the acquisition of all the company's outstanding ordinary shares, which would make it a private company, the Shenzhen-based company announced on March 10